Disulfiram use is associated with lower risk of COVID-19: A retrospective cohort study.

Disulfiram use is associated with lower risk of COVID-19: A retrospective cohort study.

Show other versions (1)

Effective, low-cost therapeutics are needed to prevent and treat COVID-19. Severe COVID-19 disease is linked to excessive inflammation. Disulfiram is an approved oral drug used to treat alcohol use disorder that is a potent anti-inflammatory agent and an inhibitor of the viral proteases. We investig...

Full description

Saved in:
Bibliographic Details
Main Authors: Nathanael Fillmore, Steven Bell, Ciyue Shen, Vinh Nguyen, Jennifer La, Maureen Dubreuil, Judith Strymish, Mary Brophy, Gautam Mehta, Hao Wu, Judy Lieberman, Nhan Do, Chris Sander
Format: article
Language:EN
Published: Public Library of Science (PLoS) 2021
Subjects:
Medicine
R
Science
Q
Online Access:https://doaj.org/article/e043e93b242c463fbbc7a2605d6b34e6
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items